SuperworthAlgorhythm EPS RIME
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- −$3.01
- Latest quarter, Q2 FY26
- −$0.25
- Fiscal year 2025
- −$7.14
Algorhythm's earnings per share was −$3.01 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.25.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$7.14 | n/a |
| FY2024 | −$343.38 | n/a |
| FY2023 | −$302.00 | n/a |
| FY2023 | −$438.00 | −1013% |
| FY2022 | $48.00 | −84% |
| FY2021 | $300.00 | n/a |
| FY2020 | −$420.00 | −800% |
| FY2019 | $60.00 | +0% |
| FY2018 | $60.00 | −75% |
| FY2017 | $240.00 | +0% |
| FY2016 | $240.00 | +300% |
| FY2015 | $60.00 | −50% |
| FY2014 | $120.00 | −75% |
| FY2013 | $480.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.25 | n/a | −$3.01 | |
| Q1 FY26 | −$0.52 | n/a | −$3.00 | |
| Q4 FY25 | −$1.09 | n/a | −$7.14 | |
| Q3 FY25 | −$1.15 | −104% | −$110.99 | |
| Q2 FY25 | −$0.24 | n/a | −$83.84 | |
| Q1 FY25 | −$4.66 | n/a | −$274.28 | |
| Q4 FY24 | −$104.94 | n/a | −$343.38 | |
| Q3 FY24 | $26.00 | n/a | −$362.44 | |
| Q2 FY24 | −$190.68 | −1292% | −$382.44 | |
| Q1 FY24 | −$73.76 | n/a | −$319.76 | |
| Q4 FY23 | −$124.00 | n/a | −$438.00 | |
| Q3 FY23 | $6.00 | −96% | −$438.00 |
Against its peers
Companies in Technology nearest Algorhythm's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| RIMEAlgorhythm | −$3.01 | |
| OXBROXBRIDGE RE HOLDINGS | $0.02 | |
| EDUCEducational Development | $0.19 | |
| GTIMGood Times Restaurants | $0.21 | +75% a year |
| MDRRMedalist Diversified | $3.84 | |
| Peer median | $0.20 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Algorhythm
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.